ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

J90 NurExone Biologic Inc

0.302
-0.044 (-12.72%)
18:01:51 - リアルタイムデータ
名称 銘柄コード 市場 種別
NurExone Biologic Inc J90 Tradegate Ordinary Share
  前日比 前日比 % 現在値 時刻
-0.044 -12.72% 0.302 18:01:51
始値 安値 高値 終値 前日終値
0.308 0.29 0.356 0.346
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2921:35GLOBENurExone Reports First Quarter 2024 Financial Results and..
2024/5/1805:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
2024/4/2521:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
2024/4/2005:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
2024/4/0221:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
2024/3/2806:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
2024/3/2306:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
2024/3/1605:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
2024/3/0906:05GLOBENurExone establishing State-of-the-Art Research and..
2024/3/0206:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
2024/2/2106:05GLOBENurExone’s Intellectual Property Portfolio Expands
2024/2/1506:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
2024/2/0306:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
2024/1/1722:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
2024/1/0522:30GLOBENurExone Announces Closing of a Private Placement for Gross..
2023/11/2922:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
2023/11/2422:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
2023/10/3022:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
2023/10/1921:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
2023/10/1121:30GLOBENurExone Secures Eureka Grant for Collaborative..
2023/10/0521:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
2023/9/2821:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
2023/9/1321:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
2023/9/0621:30GLOBENurExone Announces Closing of Second Tranche of Private..